Research Article
Transurethral Resection of Prostate Abscess: Is It Different from Conventional Transurethral Resection for Benign Prostatic Hyperplasia?
Table 1
Demographics characteristics and treatment-related side effects of two groups.
| | Parameters | Group 1
(classical resection)
() | Group 2
(modified resection)
() | value |
| | Age (yrs): mean ± SD (range) | 60.83 ± 9.32 (47–72) | 61.90 ± 8.59 (43–70) | 0.815 | | Operating time (min): mean ± SD (range) | 54.16 ± 12.19 (38–70) | 55.00 ± 12.01 (42–80) | 0.893 | | Abscess localization | | | | | Central | 3 (50.0%) | 5 (45.4%) | 0.526 | | Peripheral | 3 (50.0%) | 4 (36.4%) | | Pan-prostatic | 0 (0.0%) | 2 (18.2%) | | Diabetes mellitus | 2 (33.3%) | 7 (63.6%) | 0.491 | | Blood transfusion | 0 (0.0%) | 0 (0.0%) | 1.000 | | Residual abscess | 0 (0.0%) | 0 (0.0%) | 1.000 | | Temporary incontinence (Clavien grade I) | 3 (50.0%) | 0 (0.0%) | 0.055 | | Postoperative fever (Clavien grade II) | 1 (16.7%) | 3 (27.3%) | 0.916 | | Retrograde ejaculation (Clavien grade II) | 4 (66.7%) | 5 (45.4%) | 0.740 |
|
|
